miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.

Chengzhi Wang, Xin Li, Lijuan Zhang, Ying Chen, Ruijie Dong, Jieyou Zhang, Jingyi Zhao, Xiangdong Guo, Guangze Yang, Yan Li, Chao Gu, Qing Xi, Rongxin Zhang

International immunopharmacology 2021 Aug

filter terms:

Pancreatic cancer is a highly malignant cancer of the digestive tract. Studies have shown that in some types of cancer, a high level of microRNA-194-5p (miR-194-5p) is beneficial for controlling tumor progression, while in other cancers it plays a completely opposite role. However, how miR-194-5p affects anti-tumor immunity of pancreatic cancer remains unclear. In this study, we found that high expression of miR-194-5p in human pancreatic cancer patients is associated with a better survival rate, while increased expression of programmed cell death ligand 1 (PD-L1) in human pancreatic cancer patients is associated with a worse survival rate. In pancreatic cancer, the expression level of PD-L1 is negatively correlated with the expression level of miR-194-5p, and we identified that PD-L1 was target gene of miR-194-5p. In addition, we found that overexpression of miR-194-5p inhibited the migration, invasion and proliferation of pancreatic cancer cells in vitro. The orthotopic mouse model of pancreatic cancer shown that miR-194-5p suppressed the progression of pancreatic cancer, promoted the infiltration of CD8+ T cells in tumor immune microenvironments, and enhanced the IFN-γ production of CD8+ T cells. Consistently, the co-culture experiments showed that overexpression of miR-194-5p in tumor cell enhanced IFN-γ production by CD8+ T cells. In conclusion, miR-194-5p may serve as a novel immunotherapeutic target for pancreatic ductal adenocarcinoma (PDAC) by inhibiting the expression of PD-L1, and play important roles in inhibiting the progression of pancreatic cancer and boosting the anti-tumor effect of CD8+ T cells. Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Citation

Chengzhi Wang, Xin Li, Lijuan Zhang, Ying Chen, Ruijie Dong, Jieyou Zhang, Jingyi Zhao, Xiangdong Guo, Guangze Yang, Yan Li, Chao Gu, Qing Xi, Rongxin Zhang. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer. International immunopharmacology. 2021 Aug;97:107822